Skip to main content

Morphine Sulfate Immediate-Release Tablets Shortage

Last Updated: May 11, 2025
Status: Current

Products Affected - Description
    • Morphine tablet, Hikma, 15 mg, bottle, 100 count, NDC 00054-0235-25
    • Morphine tablet, Hikma, 15 mg, unit-dose blister pack, 100 count, NDC 00054-0235-24
    • Morphine tablet, Hikma, 30 mg, bottle, 100 count, NDC 00054-0236-25
    • Morphine tablet, Hikma, 30 mg, unit-dose blister pack, 100 count, NDC 00054-0236-24
    • Morphine tablet, SpecGX (Mallinckrodt), 15 mg, bottle, 100 count, NDC 00406-5118-01
    • Morphine tablet, SpecGX (Mallinckrodt), 15 mg, unit-dose blister pack, 100 count, NDC 00406-5118-62
    • Morphine tablet, SpecGX (Mallinckrodt), 30 mg, bottle, 100 count, NDC 00406-5119-01
    • Morphine tablet, SpecGX (Mallinckrodt), 30 mg, unit-dose blister pack, 100 count, NDC 00406-5119-62
    • Morphine tablet, Upsher-Smith, 15 mg, bottle, 100 count, NDC 00832-0273-11 - discontinued
    • Morphine tablet, Upsher-Smith, 30 mg, bottle, 100 count, NDC 00832-0274-11 - discontinued
Reason for the Shortage
    • Ascend launched morphine 15 mg and 30 mg immediate-release tablets in May 2025.
    • Hikma did not provide a reason for the shortage.
    • SpecGX has not provided us with availability information.
    • Upsher-Smith is discontinuing morphine immediate-release tablets.
Available Products
    • Morphine tablet, Ascend, 15 mg, bottle, 100 count, NDC 67877-0670-01
    • Morphine tablet, Ascend, 30 mg, bottle, 100 count, NDC 67877-0671-01

Estimated Resupply Dates

    • Hikma has morphine 15 mg immediate-release tablets in 100 count unit-dose packages on back order and the company estimates a release date in early-July 2025. All other presentations are on allocation.

Updated

Updated May 11, 2025 by Elyse MacDonald, PharmD, MS, BCPS. Created April 6, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.